Skip to article
Astra

Headache Medicine

Medication-Overuse Headache

Medication-overuse headache requires recognition of class-specific acute-medication thresholds, exclusion of alternative secondary headache causes, and a planned withdrawal strategy. Most patients stop nonopioid acute agents abruptly while migraine prevention and close follow-up address withdrawal symptoms, persistent migraine, and relapse risk.

Clinical question: How should clinicians identify and treat medication-overuse headache while managing withdrawal and the underlying primary headache disorder?

Diagnosis

Confirm the medication-use pattern before attributing chronic headache to overuse

A medication diary is the highest-yield first test.

Obtain a prospective 30-day headache and medication diary that records headache days, acute-medication days by class, dose, and use of combination products. Diagnose medication-overuse headache when headache is present on more than 15 days per month, acute headache medication has been overused for more than 3 months, and headache developed or worsened during that exposure pattern. Patients with both chronic migraine and medication-overuse headache should retain both diagnoses because withdrawal does not replace treatment of the underlying migraine disorder. NeurologyEptinezumab With Patient Education for Chronic Migraine and Medication-Overuse HeadacheWHOPHC ENG GUIDE 200 - Extranet Systems

Classify overuse by medication days rather than total pills. The operational threshold is at least 10 days per month for triptans, ergotamine, opioids, and combination analgesics; combination products include agents such as Excedrin, barbiturate-containing products, and Midrin. The threshold is at least 15 days per month for aspirin, acetaminophen, ibuprofen, naproxen sodium, or other prescription NSAIDs used alone. Apply the multiple-class overuse category when aggregate acute-medication exposure meets overuse criteria although no single class does. NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems

Do not diagnose medication-overuse headache solely because the patient has frequent medication exposure. The association between acute-medication use and frequent headache is complicated by confounding from the underlying headache burden; use the diary together with temporal worsening during overuse and response after withdrawal to reassess the diagnosis. NeurologyMedication overuse headache

Medication-day thresholds used to identify acute medication overuse. NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems
Acute medication classOveruse thresholdClinical implication
Triptans, ergotamine, opioidsAt least 10 days per month for more than 3 months NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet SystemsMeets class-specific overuse threshold in a patient with headache on more than 15 days monthly. WHOPHC ENG GUIDE 200 - Extranet Systems
Combination analgesics, including caffeine- or barbiturate-containing productsAt least 10 days per month for more than 3 months NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet SystemsAssign combination-analgesic-overuse headache when diagnostic criteria are met. WileyEuropean Academy of Neurology guideline on the ...
Acetaminophen, aspirin, NSAIDs used aloneAt least 15 days per month for more than 3 months NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet SystemsMeets simple-analgesic overuse threshold in a patient with headache on more than 15 days monthly. WHOPHC ENG GUIDE 200 - Extranet Systems
Multiple acute-medication classesAggregate use may meet criteria when no single class reaches its individual threshold. NeurologyMedication Overuse and Headache BurdenIdentify all contributing agents before constructing the withdrawal plan. NeurologyMedication Overuse and Headache Burden

Initial Assessment

Separate likely medication overuse from urgent secondary headache

Medication overuse should not terminate the secondary-headache assessment.

At the initial visit, compare the current headache with the patient's established phenotype and determine whether the frequency increase tracks acute-medication escalation. A stable migraine-like phenotype with qualifying medication exposure supports medication-overuse headache; a distinctly new phenotype, progressive focal neurologic symptoms, altered consciousness, systemic illness, or abrupt severe onset requires evaluation for an alternative secondary cause before assuming medication overuse.

Prioritize opioid exposure as a separate management branch. Opioids can contribute to medication-overuse headache and opioid-induced hyperalgesia, and abrupt discontinuation is not the default strategy for opioid overuse. Establish the prescribed and nonprescribed opioid regimen, duration of use, prior withdrawal symptoms, and concurrent sedative exposure, then select a tapering plan rather than an unsupervised abrupt stop. cellPACAP-PAC1 receptor inhibition is effective in opioid ...NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems

Refer chronic migraine with medication overuse to headache-specialist care when withdrawal fails, diagnostic uncertainty persists, opioid or other addictive-drug use complicates management, or preventive treatment selection requires escalation. Chronic migraine itself is a specialist-referral indication in the ten-step migraine management framework. NatureDiagnosis and management of migraine in ten steps

Management branches determined by the overused medication class. NatureDiagnosis and management of migraine in ten stepscellPACAP-PAC1 receptor inhibition is effective in opioid ...WHOPHC ENG GUIDE 200 - Extranet Systems
Clinical branchKey discriminatorNext action
Simple analgesic, NSAID, triptan, or combination-analgesic overuseQualifying medication-day threshold without opioid dependence concerns NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet SystemsExplain expected transient worsening and plan abrupt withdrawal. NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
Opioid overuseCurrent opioid exposure, possible dependence, or concern for opioid-induced hyperalgesia cellPACAP-PAC1 receptor inhibition is effective in opioid ...Plan gradual taper rather than routine abrupt withdrawal; involve appropriate addiction or pain-management support when needed. NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
Persistent chronic migraine after overuse is addressedHeadache remains frequent after medication withdrawal and reassessment NatureDiagnosis and management of migraine in ten stepsInitiate or optimize migraine prevention with an evidence-based chronic migraine option. NatureDiagnosis and management of migraine in ten steps
Atypical or changing headache syndromeCurrent symptoms differ materially from the prior primary-headache phenotypeEvaluate for another secondary headache disorder before attributing the presentation to medication overuse.

Detoxification

Use an explicit withdrawal plan rather than a vague reduction target

Education and a defined stop date improve implementation.

Explain that medication withdrawal is the necessary core treatment and that headache usually worsens before recovery. For overused analgesics and triptans, use abrupt discontinuation rather than gradual dose reduction. This can usually be managed in primary care when addictive drugs are not involved; opioid exposure is the major exception and should be tapered. NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems

Set the withdrawal plan in writing: identify every acute agent to stop, establish the cessation date, review anticipated headache worsening and associated symptoms, and specify how the patient will contact the practice if withdrawal becomes unmanageable. Detoxification commonly produces predictable withdrawal symptoms, and successful detoxification is associated with improved headache outcomes and fewer monthly headache days by 8 weeks. ScienceDirectMedication-overuse headache: Bridging therapies for detoxification

Avoid allowing a bridge plan to become replacement overuse. Bridging therapies have been used to reduce withdrawal-headache intensity and associated symptoms, but novel acute agents including ditans and gepants require further study in this setting. If prednisone is selected for withdrawal symptoms, one cited primary-care guide lists prednisone 60 mg as possibly effective; the same guide lists amitriptyline up to 50 mg as possibly effective for withdrawal symptoms. ScienceDirectMedication-overuse headache: Bridging therapies for detoxificationWHOPHC ENG GUIDE 200 - Extranet Systems

Practical withdrawal sequence for medication-overuse headache. NatureDiagnosis and management of migraine in ten stepsScienceDirectMedication-overuse headache: Bridging therapies for detoxificationWHOPHC ENG GUIDE 200 - Extranet Systems
Time pointRequired actionDecision checkpoint
Before withdrawalQuantify medication days by class and identify the underlying headache disorder with a diary. NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet SystemsDetermine whether opioid exposure requires tapering rather than abrupt cessation. NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems
Withdrawal startAbruptly stop overused analgesics or triptans; start a tapering strategy for opioids. NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet SystemsCounsel that headache may worsen before recovery. NatureDiagnosis and management of migraine in ten stepsScienceDirectMedication-overuse headache: Bridging therapies for detoxification
During withdrawalStart or optimize preventive treatment for the antecedent headache disorder when clinically appropriate. NatureDiagnosis and management of migraine in ten stepsDo not substitute a new frequently used acute agent without tracking medication days.
About 8 weeksReview headache days and acute-medication days after detoxification. ScienceDirectMedication-overuse headache: Bridging therapies for detoxificationIf headache remains frequent, reassess diagnosis and optimize preventive therapy. NatureDiagnosis and management of migraine in ten steps

Preventive therapy during withdrawal

Preventive treatment for the antecedent migraine disorder can begin in parallel with acute-medication withdrawal or be initiated when the underlying headache disorder re-emerges; this timing remains debated. For chronic migraine once medication overuse has been addressed or excluded, evidence-based preventive options include topiramate, onabotulinumtoxinA, and CGRP monoclonal antibodies. NatureDiagnosis and management of migraine in ten steps

When topiramate is chosen in medication-overuse headache, a cited primary-care guide identifies a maximum daily dose of 200 mg. Select the preventive agent according to the underlying migraine phenotype, prior response, comorbidities, adverse-effect risk, access, and patient preference rather than using detoxification as the sole treatment. WHOPHC ENG GUIDE 200 - Extranet SystemsNatureDiagnosis and management of migraine in ten steps

Follow-up

Measure response by headache burden and medication days

Withdrawal success does not eliminate the need for migraine management.

At follow-up, review the same diary fields used at baseline: monthly headache days, monthly acute-medication days by class, attack severity, and migraine-related disability. Evaluate response shortly after initiating or changing therapy, at 2 to 3 months, then every 6 to 12 months once the regimen is stable. NatureDiagnosis and management of migraine in ten steps

If outcomes remain suboptimal, first review whether medication overuse has recurred, whether the post-withdrawal phenotype still supports migraine, and whether the preventive strategy is being used and tolerated. A patient whose medication use no longer meets overuse thresholds but who continues to have frequent migraine needs escalation of migraine prevention rather than repeated detoxification alone. NatureDiagnosis and management of migraine in ten stepsNeurologyMedication Overuse and Headache Burden

Prevent recurrence by discussing class-specific medication-day limits before prescribing or refilling acute treatment. Frequent acute-medication use is a modifiable risk factor for headache-frequency progression, and patients with migraine should be educated about medication-overuse risk before use becomes established. NatureDiagnosis and management of migraine in ten stepsNeurologyMedication overuse headache

Follow-up metrics that determine the next management step. NatureDiagnosis and management of migraine in ten stepsNeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet Systems
MetricInterpretationNext step
Acute-medication days by classAt least 10 days monthly for triptans, opioids, ergots, or combination analgesics, or at least 15 days monthly for simple analgesics, suggests recurrent overuse. NeurologyMedication Overuse and Headache BurdenWHOPHC ENG GUIDE 200 - Extranet SystemsReinstitute a medication-withdrawal plan and reassess the preventive regimen. NatureDiagnosis and management of migraine in ten steps
Headache frequency after withdrawalPersistent frequent headaches may reflect inadequately treated chronic migraine or an alternative diagnosis. NatureDiagnosis and management of migraine in ten stepsNeurologyMedication overuse headacheReassess phenotype and optimize chronic migraine prevention. NatureDiagnosis and management of migraine in ten steps
Attack severity and disabilityPersistent burden despite reduced acute-medication use indicates incomplete control of the underlying headache disorder. NatureDiagnosis and management of migraine in ten stepsAdjust preventive treatment and assess adherence and tolerability. NatureDiagnosis and management of migraine in ten steps
Opioid useContinued opioid exposure may sustain medication-overuse headache or opioid-induced hyperalgesia. cellPACAP-PAC1 receptor inhibition is effective in opioid ...Continue an individualized tapering and multidisciplinary management plan. NatureDiagnosis and management of migraine in ten stepsWHOPHC ENG GUIDE 200 - Extranet Systems

References

  1. Comparison of 3 Treatment Strategies for Medication ...jamanetwork.com · jamanetwork.com
  2. Diagnosis and management of migraine in ten stepswww.nature.com · www.nature.com
  3. Migraine | Nature Reviews Disease Primerswww.nature.com · www.nature.com
  4. PACAP-PAC1 receptor inhibition is effective in opioid ...www.cell.com · www.cell.com
  5. The Many Faces of Medication‐Overuse Headache in Clinical ...headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
  6. Treatment of medication overuse headache – guideline ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  7. American Headache Society 66th Annual Scientific Meeting ...headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
  8. overuse headacheonlinelibrary.wiley.com · onlinelibrary.wiley.com
  9. European Academy of Neurology guideline on the ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  10. Evidence Regarding Medication Overuse Headache in ...headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
  11. American Headache Society 67th Annual Scientific Meeting ...headachejournal.onlinelibrary.wiley.com · headachejournal.onlinelibrary.wiley.com
  12. Medication Overuse - an overviewwww.sciencedirect.com · www.sciencedirect.com
  13. Medication-overuse headache: Bridging therapies for detoxificationwww.sciencedirect.com · www.sciencedirect.com
  14. Cluster Headache - an overviewwww.sciencedirect.com · www.sciencedirect.com
  15. Drug Detoxification - an overviewwww.sciencedirect.com · www.sciencedirect.com
  16. SPINEPASS Randomized Clinical Trial Protocol | Physical ...academic.oup.com · academic.oup.com
  17. Primary Care Management of Headache - Oxford Academicacademic.oup.com · academic.oup.com
  18. Pilot Study of Amitriptyline in the Prophylactic Treatment of ...academic.oup.com · academic.oup.com
  19. Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headachewww.neurology.org · www.neurology.org
  20. Medication Overuse and Headache Burdenwww.neurology.org · www.neurology.org
  21. Medication overuse headachewww.neurology.org · www.neurology.org
  22. PHC ENG GUIDE 200 - Extranet Systemsextranet.who.int · extranet.who.int
  23. Why Should We Prescribe Medications to Treat Alcohol ...www.aasld.org · www.aasld.org
  24. Electronic Signature Pagecdn.clinicaltrials.gov · cdn.clinicaltrials.gov